What's new in the biology and treatment of undifferentiated carcinoma of nasopharyngeal type?
Carbone
A
A
Division of Pathology, National Cancer Institute, IRCCS, Aviano, Italy.
Dolcetti
R
R
Shaha
A R
AR
Gloghini
A
A
Molinari
R
R
Rinaldo
A
A
Boiocchi
M
M
Wei
W I
WI
Ferlito
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001695:Biology / Q000379:methods*; D002277:Carcinoma / Q000473:pathology / Q000628:therapy* / Q000821:virology; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000628:therapy* / Q000821:virology; D003131:Combined Modality Therapy; D004279:DNA, Viral / Q000235:genetics; D018450:Disease Progression; D020031:Epstein-Barr Virus Infections / Q000276:immunology / Q000821:virology; D019309:Epstein-Barr Virus Nuclear Antigens / Q000276:immunology; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000276:immunology; D009303:Nasopharyngeal Neoplasms / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D014763:Viral Matrix Proteins / Q000276:immunology
D004279:DNA, Viral; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D019309:Epstein-Barr Virus Nuclear Antigens; D014763:Viral Matrix Proteins; D018799:Intercellular Adhesion Molecule-1; C417029:EBV-encoded nuclear antigen 1